BIOS Capital Management, LP Long-Term Concentrated

CIK: 0001813845 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value ($000): $79,177 (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 84.6%

Value ($000) $66,980 Shares 9,893,651 Est. Cost $8.16 Unrealized -1.6%

LTRN LANTERN PHARMA INC 5.4%

Value ($000) $4,275 Shares 1,207,709 Est. Cost $3.42 Unrealized +21.2%

RNTX REIN THERAPEUTICS INC 3.8%

Value ($000) $2,993 Shares 1,690,751 Est. Cost $3.03 Unrealized -30.7%

CGTX COGNITION THERAPEUTICS INC 3.2%

Value ($000) $2,525 Shares 6,000,000 Est. Cost $0.49 Unrealized +18.9%

— IN8BIO INC 1.8%

Value ($000) $1,428 Shares 8,600,001 Est. Cost $0.26 Unrealized —

IRD OPUS GENETICS INC 1.2%

Value ($000) $977 Shares 995,249 Est. Cost $1.15 Unrealized -2.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	9,893,651	$66,980	84.6%	$8.16	-1.6%	COM	005083100
LTRN	LANTERN PHARMA INC	1,207,709	$4,275	5.4%	$3.42	+21.2%	COM	51654W101
RNTX	REIN THERAPEUTICS INC	1,690,751	$2,993	3.8%	$3.03	-30.7%	COM NEW	00887A204
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$2,525	3.2%	$0.49	+18.9%	COM	19243B102
—	IN8BIO INC	8,600,001	$1,428	1.8%	$0.26	—	COM	45674E109
IRD	OPUS GENETICS INC	995,249	$977	1.2%	$1.15	-2.7%	COM	67577R102